CD20 (pan-B cell antigen) expression on bone marrow-derived T cells

American Journal of Clinical Pathology

Volumn 106, Issue 1, 1996, Pages 78-81

  Algino, Kenneth M ^a   Thomason, Ronald W ^b   King, David E ^a   Montiel, Milka M ^a   Craig, Fiona E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b USAF Medical Center Keesler   (United States)

Author keywords

Hematologic diseases; Hematopoietic differentiation antigens; Immunophenotyping; Lymphocytes

Indexed keywords

CD20 ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; FLOW CYTOMETRY; HUMAN; LEUKEMIA; LYMPHOBLASTOMA; LYMPHOCYTOMA; LYMPHOMA; MULTIPLE MYELOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029895079     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.1.78     Document Type: Article

References (17)

1. Tedder, TF, McIntyre, G, Schlossman, SF. Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B lymphocytes. Mol Immunol 1988;25:1321-1330.
2. Tedder, TF, Klejman, G, Schlossman, SF, Saito H. Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). J Immunol 1989;142:2560-2568.
3. Foon, KA, Schroff, RW, Gale RP. Surface markers on leukemia and lymphoma cells: Recent advances. Blood 1982;60:1-19.
4. Hokland P, Ritz J, Schlossman SF, Nadler LM. Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol 1985;135:1746-1751.
5. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow. II. Normal B-lymphocyte development. Blood 1987;70:1316-1324.
6. Hultin LE, Hausner MA, Hultin PM, Giogi JV. CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry 1993;14:196-204.
7. Quinantilla-Martinez L, Preffer F, Rubin D, Ferr, JA, Harris NL. CD20+ T-cell lymphoma: Neoplastic transformation of a normal T-cell subset. Am J Clin Pathol 1994;102:483-489.
8. Warzynski MJ, Graham DM, Axtell RA, Zakem MH, Rotman RK. Low level CD20 expression on T-cell malignancies. Cytometry 1994;18:88-92.
9. Hamilton-Dutoit SJ, Pallesen G. B-cell associated monoclonal antibody L26 may occasionally label T-cell lymphoma. APMIS 1989;97:1033-1036.
10. Myskow MW, Salter DM, Krajewski AS. Reactivity of T-cell lymphomas with monoclonal antibody L-26. J Pathol 1988;155: 344.
11. Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990;11:453-459.
12. Linder J, Ye Y. Armitage JO, Weisenburger DD. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissues. Mod Pathol 1988;1:29-34.
13. Mason DY,Comans-Bitter WM, Cordell JL, Verhoeven MAJ, van Dongen JJM. Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. Am J Pathol 1990;136: 1215-1222.
14. Norton, AJ, Isaacson, PG. Monoclonal antibody L26: An antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues. J Clin Pathol 1987;1987:1405-1412.
15. Pallesen G. Immunohistological analysis of tissue specificity of the 52 workshop anti-B lymphocyte monoclonal antibodies. Cancer Rev 1988;8:277-288.
16. Hayakawa K, Hardy RR. Normal, autoimmune, and malignant CD5+ B cells: The LY-1 lineage. Ann Rev Immunol 1988;6: 197-218.
17. Kipps TJ. The CD5 B-cell. Adv Immunol 1989;47:117-185.